Your browser is no longer supported. Please, upgrade your browser.
Settings
HZNP Horizon Pharma Public Limited Company daily Stock Chart
HZNP [NASD]
Horizon Pharma Public Limited Company
Index- P/E- EPS (ttm)-2.69 Insider Own0.70% Shs Outstand165.78M Perf Week-4.72%
Market Cap2.01B Forward P/E9.67 EPS next Y1.25 Insider Trans0.87% Shs Float161.98M Perf Month-8.05%
Income-436.50M PEG- EPS next Q0.23 Inst Own91.30% Short Float12.27% Perf Quarter5.95%
Sales1.03B P/S1.95 EPS this Y-509.50% Inst Trans2.80% Short Ratio5.27 Perf Half Y-16.60%
Book/sh6.31 P/B1.92 EPS next Y15.82% ROA-10.80% Target Price17.00 Perf Year-35.96%
Cash/sh3.34 P/C3.62 EPS next 5Y12.90% ROE-35.90% 52W Range9.45 - 21.98 Perf YTD-25.15%
Dividend- P/FCF6.07 EPS past 5Y39.30% ROI-2.80% 52W High-44.90% Beta1.51
Dividend %- Quick Ratio1.40 Sales past 5Y169.30% Gross Margin51.00% 52W Low28.15% ATR0.52
Employees935 Current Ratio1.60 Sales Q/Q12.50% Oper. Margin-43.00% RSI (14)39.40 Volatility4.09% 3.64%
OptionableYes Debt/Eq1.84 EPS Q/Q- Profit Margin-42.40% Rel Volume0.53 Prev Close12.10
ShortableYes LT Debt/Eq1.83 EarningsAug 07 BMO Payout- Avg Volume3.77M Price12.11
Recom1.90 SMA20-7.68% SMA50-5.53% SMA200-14.17% Volume2,046,969 Change0.08%
Jun-16-17Initiated Cantor Fitzgerald Overweight $13
May-09-17Reiterated Stifel Buy $35 → $20
May-09-17Downgrade Mizuho Buy → Neutral $22 → $10
Feb-28-17Reiterated Mizuho Buy $25 → $22
Dec-16-16Upgrade Mizuho Neutral → Buy $14 → $25
Dec-09-16Downgrade Mizuho Buy → Neutral $30 → $14
Nov-28-16Upgrade Citigroup Neutral → Buy
Nov-08-16Reiterated Mizuho Buy $29 → $30
Oct-31-16Reiterated Mizuho Buy $33 → $29
Sep-13-16Reiterated Mizuho Buy $30 → $33
Jul-11-16Upgrade Morgan Stanley Underweight → Equal-Weight $24
Jun-06-16Initiated Goldman Buy $24
May-10-16Reiterated Mizuho Buy $25 → $24
May-03-16Reiterated Mizuho Buy $34 → $25
Jan-19-16Resumed Jefferies Buy $31
Jan-06-16Resumed Citigroup Neutral
Dec-17-15Initiated Goldman Buy
Dec-14-15Reiterated Mizuho Buy $34 → $36
Dec-03-15Resumed Morgan Stanley Underweight $23
Nov-23-15Resumed Jefferies Buy
Sep-19-17 08:01AM  IIROC Trade Halt - Horizon Petroleum Ltd. Newsfile
Sep-15-17 03:44PM  Horizon Pharma weighs sale of primary care unit -sources Reuters
Sep-14-17 10:21AM  Horizon Pharma Plc breached its 50 day moving average in a Bearish Manner : HZNP-US : September 14, 2017 Capital Cube
Sep-13-17 06:36PM  ETFs with exposure to Horizon Pharma Plc : September 13, 2017 Capital Cube -5.29%
04:05PM  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Sep-11-17 01:24PM  Horizon Pharma Plc :HZNP-US: Earnings Analysis: Q2, 2017 By the Numbers : September 11, 2017 Capital Cube
08:05AM  See what the IHS Markit Score report has to say about Horizon Pharma PLC. Markit
08:00AM  Horizon Pharma plc Names Irina Konstantinovsky Executive Vice President, Chief Human Resources Officer GlobeNewswire
Sep-07-17 08:04AM  See what the IHS Markit Score report has to say about Horizon Pharma PLC. Markit
Sep-05-17 04:05PM  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Aug-24-17 08:00AM  Horizon Pharma plc to Participate in Morgan Stanley 15th Annual Global Healthcare Conference GlobeNewswire
07:30AM  Nuvo Pharmaceuticals Secures Credit Facility from the Royal Bank of Canada CNW Group
Aug-21-17 06:26PM  Horizon Pharma Plc Value Analysis (NASDAQ:HZNP) : August 21, 2017 Capital Cube
Aug-18-17 08:48AM  Horizon Pharma (HZNP) Soars: Stock Adds 10.5% in Session Zacks
08:10AM  Today's Research Reports on Stocks to Watch: TherapeuticsMD Inc. and Horizon Pharma ACCESSWIRE
Aug-17-17 03:50PM  Here's Why Horizon Pharma Gained as Much as 13.1% Today Motley Fool +10.51%
Aug-16-17 08:04AM  See what the IHS Markit Score report has to say about Horizon Pharma PLC. Markit
Aug-13-17 11:30AM  Edited Transcript of HZNP earnings conference call or presentation 7-Aug-17 12:00pm GMT Thomson Reuters StreetEvents
Aug-11-17 08:04AM  IHS Markit Score upgrades Horizon Pharma PLC to 40 out of 100, despite ranking positively in only one IHS Markit category. Markit
Aug-10-17 09:43AM  Horizon Pharma Plc breached its 50 day moving average in a Bearish Manner : HZNP-US : August 10, 2017 Capital Cube
08:04AM  IHS Markit Score downgrades Horizon Pharma PLC to 30 out of 100, ranking positively in only one out of three available IHS Markit categories. Markit
Aug-09-17 05:00PM  Nuvo Pharmaceuticals Announces 2017 Second Quarter Results CNW Group
Aug-08-17 10:05AM  Horizon Pharma (HZNP) Q2 Earnings & Sales Top, Raises View Zacks -7.89%
08:10AM  Todays Research Reports on Stocks to Watch: Horizon Pharma and Arrowhead Pharmaceuticals ACCESSWIRE
Aug-07-17 11:58PM  Horizon Pharma reports 2Q loss Associated Press
11:54AM  Horizon Pharma PLC (HZNP) Q2 Report Sends Shares Surging InvestorPlace
10:41AM  Energy Losses Put Dow's Record-Breaking Streak in Jeopardy TheStreet.com
10:40AM  Horizon Pharma Wins Big in Q2 24/7 Wall St.
09:53AM  Why Horizon Pharma plc Stock Is Rising Today Motley Fool
09:28AM  Stocks to Watch: Brighthouse, Berkshire Hathaway, Tesla, Horizon Pharma The Wall Street Journal
09:27AM  Biotech Movers: Second Quarter Results, Increased Outlook Send Horizon Pharma Shares Higher TheStreet.com
08:43AM  Morning Movers: Tyson Jumps, Horizon Soars, Teva Tumbles Barrons.com
08:09AM  Early movers: TSN, MAR, BABA, COL, DB, TSLA, GM & more CNBC
07:59AM  Horizon Pharma (HZNP) Tops Earnings in Q2, Shares Up Zacks
07:49AM  Horizon Pharma shares surge 19% on Q2 profit, revenue beats and upbeat guidance MarketWatch
07:00AM  Horizon Pharma plc Announces Second-Quarter and Year-to-Date 2017 Results and Increases Full-Year 2017 Net Sales and Adjusted EBITDA Guidance GlobeNewswire
06:00AM  Investor Network: Horizon Pharma plc to Host Earnings Call ACCESSWIRE
Aug-03-17 07:00AM  Horizon Pharma plc Appoints Pascale Witz and James Shannon, M.D. to Board of Directors GlobeNewswire
Jul-31-17 11:13AM  Can Horizon Pharma (HZNP) Spring a Surprise in Q2 Earnings? Zacks
Jul-25-17 08:00AM  Horizon Pharma plc Launches CGD Connections to Deliver Support and Resources Created by and for the Chronic Granulomatous Disease (CGD) Community GlobeNewswire
Jul-24-17 04:37PM  ETFs with exposure to Horizon Pharma Plc : July 24, 2017 Capital Cube
Jul-14-17 03:00PM  ETFs with exposure to Horizon Pharma Plc : July 14, 2017 Capital Cube
08:00AM  Horizon Pharma plc Announces Four Poster Presentations on PROCYSBI® (Cysteamine Bitartrate) Delayed-Release Capsules at Cystinosis Research Network 2017 Family Conference GlobeNewswire
Jul-10-17 10:50AM  Horizon Pharma plc to Host Second-Quarter 2017 Conference Call and Webcast on Aug. 7, 2017 GlobeNewswire
Jun-28-17 03:28PM  Horizon Pharma Plc Value Analysis (NASDAQ:HZNP) : June 28, 2017 Capital Cube
Jun-27-17 08:24AM  Horizon Pharma Plc breached its 50 day moving average in a Bullish Manner : HZNP-US : June 27, 2017 Capital Cube
07:00AM  Horizon Pharma plc Announces District Court Decision to Uphold VIMOVO® (naproxen/esomeprazole magnesium) Patents GlobeNewswire
Jun-26-17 01:08PM  3 Cheap Healthcare Stocks You Can Buy Right Now Motley Fool
Jun-23-17 11:00AM  Horizon Pharma plc Completes Sale of European Marketing Rights for PROCYSBI® (cysteamine bitartrate) delayed-release capsules and QUINSAIR (levofloxacin nebuliser solution) in Europe, Middle East and Africa (EMEA) Regions to Chiesi Farmaceutici S.p.A. GlobeNewswire
Jun-20-17 03:00PM  Horizon Pharma plc Partners with Global Genes® to Unite the Rare Disease Community at the Biotechnology Innovation Organization (BIO) International Convention GlobeNewswire
11:24AM  Horizon Pharma Gets Health Canada Approval for Procysbi Zacks
Jun-19-17 08:00AM  Horizon Pharma plc Announces Health Canada Approval of PROCYSBI (Cysteamine Delayed-Release Capsules) for the Treatment of Nephropathic Cystinosis GlobeNewswire
Jun-16-17 10:54AM  Valeant: Stop Looking in the Rearview Mirror! Barrons.com
Jun-14-17 09:05AM  Horizon Pharma plc Presents New Data Analyses Further Demonstrating Clinical Benefit of KRYSTEXXA® (pegloticase) in Patients with Uncontrolled Gout GlobeNewswire
09:00AM  Epidemiologic Study Findings Show Over 400 Percent Increase in Gout Patient Hospitalizations Since 1993 GlobeNewswire
Jun-12-17 09:03AM  Horizon Pharma (HZNP) Up 11.3% Since Earnings Report: Can It Continue? Zacks
Jun-08-17 08:06PM  3 Value Stocks You Probably Haven't Considered Motley Fool
May-31-17 08:48AM  Falling Earnings Estimates Signal Weakness Ahead for Horizon Pharma (HZNP) Zacks
May-26-17 01:11PM  ETFs with exposure to Horizon Pharma Plc : May 26, 2017 Capital Cube
12:46PM  5 Stocks Setting Up for Big Breakouts TheStreet.com
07:00AM  Horizon Pharma plc to Participate in Upcoming Conferences GlobeNewswire
May-25-17 01:00PM  Horizon Pharma plc Named One of the Best Workplaces in Chicago by Fortune GlobeNewswire
07:23AM  Horizon (HZNP) Sells European Rights for Procysbi & Quinsair Zacks
May-23-17 04:05PM  Horizon Pharma plc Announces Agreement to Sell European Marketing Rights to PROCYSBI® (cysteamine bitartrate) delayed-release capsules and QUINSAIR (levofloxacin inhalation solution) in Europe, Middle East and Africa (EMEA) Regions to Chiesi Farmaceutici S.p.A. GlobeNewswire
May-22-17 12:06PM  Julian Robertson's Tiger Mgmt Sold Apple and Google, Bought Adobe in Q1 Investopedia
May-15-17 07:35AM  Nuvo Pharmaceuticals Inc. Announces Topline Results from European Ankle Sprain Study with Pennsaid® 2% CNW Group +5.50%
07:30AM  Nuvo Pharmaceuticals Announces District Court Decision to Uphold U.S. Pennsaid® 2% Patent CNW Group
07:00AM  Horizon Pharma plc Announces District Court Decision to Uphold PENNSAID® (diclofenac sodium topical solution) 2% w/w Patent GlobeNewswire
May-12-17 01:15PM  Edited Transcript of HZNP earnings conference call or presentation 8-May-17 11:30am GMT Thomson Reuters StreetEvents
May-11-17 05:00PM  Nuvo Pharmaceuticals Announces Director Election Results of its Annual General Meeting CNW Group +6.79%
04:51PM  ETFs with exposure to Horizon Pharma Plc : May 11, 2017 Capital Cube
09:00AM  Horizon Pharma plc Announces Michelle Parsons as a 2017 Healthcare Businesswomen's Association Luminary GlobeNewswire
May-10-17 05:00PM  Nuvo Pharmaceuticals Announces 2017 First Quarter Results CNW Group
May-09-17 12:58PM  Pharma Lobby Ousts 22 Drugmakers Amid U.S. Pricing Debate Bloomberg
11:42AM  Horizon Pharma Plc :HZNP-US: Earnings Analysis: Q1, 2017 By the Numbers : May 9, 2017 Capital Cube
10:44AM  Horizon (HZNP) Falls on Q1 Earnings Miss, Guidance Trimmed Zacks
10:07AM  Horizon Pharma, Inc. -- Moody's affirms Horizon Pharma; revises outlook to negative Moody's
08:57AM  Horizon Pharma Plc breached its 50 day moving average in a Bearish Manner : HZNP-US : May 9, 2017 Capital Cube
08:00AM  Today's Research Reports on Stocks to Watch: Horizon Pharma and PTC Therapeutics Accesswire
May-08-17 05:00PM  Why Liberty Global, Horizon Pharma, and Synchronoss Technologies Slumped Today Motley Fool -35.04%
04:36PM  These Drugmakers Plunged On Consensus-Lagging Q1 Sales, Losses Investor's Business Daily
03:30PM  Here's Why Shares of Horizon Pharma (HZNP) are Cratering Today Zacks
02:08PM  Why Horizon Pharma plc Stock Is Crashing Today Motley Fool
12:16PM  Story Stocks from Briefing.com Briefing.com
11:33AM  Horizon Pharma Sinks on Missed Earnings and Guidance 24/7 Wall St.
11:00AM  Biotech And Pharma Industry And Stock News Investor's Business Daily
09:29AM  Biotech Movers: Horizon, OncoMed, Inovio TheStreet.com
09:02AM  Horizon Pharma (HZNP) Misses Q1 Earnings, Shares Crash Zacks
08:54AM  Morning Movers: Horizon Plunges; Verizon Bids On Straight Path; Tyson Tumbles Barrons.com
07:30AM  Horizon Pharma reports 1Q loss Associated Press
07:22AM  Horizon Pharma slide 16% on weaker-than-expected earnings MarketWatch
07:00AM  Investor Network: Horizon Pharma plc to Host Earnings Call Accesswire
07:00AM  Horizon Pharma plc Announces First-Quarter 2017 Results and Revises Full-Year 2017 Net Sales and Adjusted EBITDA Guidance GlobeNewswire
06:55AM  Horizon Pharma plc Announces Agreement to Acquire River Vision Development Corp. and Teprotumumab (RV001), a Biologic in Late-Stage Development for Rare Eye Disease GlobeNewswire
May-05-17 08:42AM  Should You Buy Horizon Pharma PLC (HZNP) Ahead of Earnings? Zacks
May-04-17 05:21PM  Is Horizon Pharma (HZNP) Poised for a Beat in Q1 Earnings? Zacks
May-01-17 05:02PM  Horizon Pharma Plc Value Analysis (NASDAQ:HZNP) : May 1, 2017 Capital Cube
07:00AM  Horizon Pharma plc Announces FDA Approval to Expand the Age Range for RAVICTI® (glycerol phenylbutyrate) Oral Liquid to People with Urea Cycle Disorders Two Months of Age and Older GlobeNewswire
Apr-28-17 08:20AM  Horizon Pharma Plc breached its 50 day moving average in a Bullish Manner : HZNP-US : April 28, 2017 Capital Cube
Apr-18-17 06:00AM  The 7 Most Expensive Prescription Drugs in the World Motley Fool
Horizon Pharma Public Limited Company, a biopharmaceutical company, engages in identifying, developing, acquiring, and commercializing medicines for the treatment of orphan diseases, arthritis, pain, and inflammation and inflammatory diseases in the United States and internationally. The company's marketed medicine portfolio consists of ACTIMMUNE for the treatment of chronic granulomatous disease and malignant osteopetrosis; RAVICTI and BUPHENYL/AMMONAPS to treat urea cycle disorders; PROCYSBI for the treatment of nephropathic cystinosis; QUINSAIR for the treatment of chronic pulmonary infections due to pseudomonas aeruginosa in cystic fibrosis patients; and KRYSTEXXA to treat chronic refractory gout. Its products also include RAYOS/LODOTRA for the treatment of rheumatoid arthritis, polymyalgia rheumatic, systemic lupus erythematosus, and multiple other indications; DUEXIS to treat signs and symptoms of osteoarthritis and rheumatoid arthritis; MIGERGOT for the treatment of vascular headache; PENNSAID 2% to treat pain of osteoarthritis of the knees; and VIMOVO for the treatment of signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. The company has collaboration agreements with Fox Chase Cancer Center to study ACTIMMUNE in combination with PD-1/PD-L1 inhibitors for use in the treatment of various forms of cancer; and Alliance for Lupus Research (ALR) to study the effect of RAYOS on the fatigue experienced by systemic lupus erythematosus (SLE) patients. Horizon Pharma Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GREY MICHAEL GDirectorMay 10Buy9.4810,00094,80025,448May 10 07:22 PM
Carey RobertEVP, Chief Business OfficerMar 01Sale16.0030,000480,00095,408Mar 02 06:40 PM
Carey RobertEVP, Chief Business OfficerFeb 28Sale16.481,80829,796125,408Mar 02 06:40 PM
ACKERMAN TIMOTHY J.SVP, Commercial OperationsJan 10Option Exercise6.539,67563,14941,129Jan 11 04:29 PM
Walbert Timothy PChairman, President and CEOJan 02Option Exercise0.0081,6750416,549Jan 04 06:57 PM
SHERMAN JEFFREY WEVP and Chief Medical OfficerDec 16Option Exercise2.408,50020,400167,750Dec 19 06:15 PM